WEBINAR - Archives

Prebiotics & Probiotics for Metabolic Disorders with Stephen Olmstead, MD


Obesity, metabolic syndrome, and type 2 diabetes mellitus and associated disorders are a growing pandemic worldwide. Once simplistically thought to be the result of over eating and lack of physical activity, these abnormalities of metabolism are now known to be more complex. This presentation will foster an appreciation of the links between intestinal microorganisms and abnormal weight and sugar metabolism and provide further insights into how diet, probiotics, and prebiotics may be beneficially used in the setting of obesity, metabolic syndrome, and type 2 diabetes mellitus.

Stephen F. Olmstead, MD, is Chief Science Officer at ProThera, Inc. where he directs clinical trials of ProThera® and Klaire Labs™ nutraceutical products. He received his MD from the University of New Mexico in 1979 and completed his Internal Medicine residency at Harvard Medical School, Massachusetts General Hospital in 1982 and fellowship in Cardiovascular Diseases at the University of Washington in 1987. His current research focuses on the use of enzymes and chelating agents to disrupt pathogenic GI biofilm and pre- and probiotics to restore gut microbial balance.

Hawthorn University students and graduates are also encouraged to join in on post-webinar discussions on the Hawthorn Forums.  On your forum, just navigate to General Questions and Postings > Teleclasses and Webinars to post or join in on any discussions. 

Click Here for a PDF copy of the slide presentation used in this webinar.